Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: A prospective multicenter study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  De Angelis, Giulia ^a   Restuccia, Giovanni ^a   Venturiello, Silvia ^a   Cauda, Roberto ^a   Malhotra Kumar, Surbhi ^b   Goossens, Herman ^b   Schrenzel, Jacques ^c   Tacconelli, Evelina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Antibiotic resistance; Antibiotic use; ESBL; MRSA; Saturn

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; ENTEROBACTERIACEAE INFECTION; EUROPE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION RATE; INFECTION RISK; LONGITUDINAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; ADOLESCENT; AGED; CASE CONTROL STUDY; CHILD; CLINICAL TRIAL; CROSS INFECTION; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENZYMOLOGY; FECES; FEMALE; HOSPITAL; INFANT; ISOLATION AND PURIFICATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; NOSE; PRESCHOOL CHILD; PREVALENCE; SECRETION; STAPHYLOCOCCUS INFECTION; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EUROPE; FECES; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE; PREVALENCE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84858958646     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-74     Document Type: Article

References (13)

1. Muto CA. Why are antibiotic-resistant nosocomial infections spiraling out of control?. Infect Contr Hosp Epidemiol 2004, 26(1):10-12.
2. Wenzel RP. Health care-associated infections: major issues in the early years of the 21st century. Clin Infect Dis 2007, 45(Suppl 1):S85-S88.
3. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
4. Tacconelli E, De Angelis G, Cataldo MA, Mantengoli E, Spanu T, Pan A, Corti G, Radice A, Stolzuoli L, Antinori S, Paradisi F, Carosi G, Bernabei R, Antonelli M, Fadda G, Rossolini GM, Cauda R. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 2009, 53(10):4264-4269. 10.1128/AAC.00431-09, 2764223, 19667289.
5. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Cueto M, Galvez J, Perea EJ, Pascual A. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect 2008, 14(2):180-183.
6. Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, Kim WJ. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinical-epidemiologic analysis. Am J Infect Control 2009, 37(9):734-740. 10.1016/j.ajic.2008.09.025, 19188004.
7. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta- analysis. J Antimicrob Chemother 2008, 61(1):26-38.
8. Hyle EP, Bilker WB, Gasink LB, Lautenbach E. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol 2007, 28(6):647-654. 10.1086/516798, 17520535.
9. Carmeli Y, Samore MH, Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med 1999, 159(20):2461-2468. 10.1001/archinte.159.20.2461, 10665895.
10. Tacconelli E. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis 2009, 22(4):352-358. 10.1097/QCO.0b013e32832d52e0, 19461514.
11. Malhotra-Kumar S, Abrahantes JC, Sabiiti W, Lammens C, Vercauteren G, Ieven M, Molenberghs G, Aerts M, Goossens H, . MOSAR WP2 Study Team Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2010, 48(4):1040-1046. 10.1128/JCM.01745-09, 2849574, 20164268, MOSAR WP2 Study Team.
12. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing 2009, CLSI, Wayne, PA, 19th Information supplement M100-S19, Clinical and Laboratory Standards Institute.
13. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 2006, 42(Suppl 4):S153-S163.